Document Detail

EU framework 6 project: predictive toxicology (PredTox)--overview and outcome.
MedLine Citation:
PMID:  20955723     Owner:  NLM     Status:  MEDLINE    
In this publication, we report the outcome of the integrated EU Framework 6 PROJECT: Predictive Toxicology (PredTox), including methodological aspects and overall conclusions. Specific details including data analysis and interpretation are reported in separate articles in this issue. The project, partly funded by the EU, was carried out by a consortium of 15 pharmaceutical companies, 2 SMEs, and 3 universities. The effects of 16 test compounds were characterized using conventional toxicological parameters and "omics" technologies. The three major observed toxicities, liver hypertrophy, bile duct necrosis and/or cholestasis, and kidney proximal tubular damage were analyzed in detail. The combined approach of "omics" and conventional toxicology proved a useful tool for mechanistic investigations and the identification of putative biomarkers. In our hands and in combination with histopathological assessment, target organ transcriptomics was the most prolific approach for the generation of mechanistic hypotheses. Proteomics approaches were relatively time-consuming and required careful standardization. NMR-based metabolomics detected metabolite changes accompanying histopathological findings, providing limited additional mechanistic information. Conversely, targeted metabolite profiling with LC/GC-MS was very useful for the investigation of bile duct necrosis/cholestasis. In general, both proteomics and metabolomics were supportive of other findings. Thus, the outcome of this program indicates that "omics" technologies can help toxicologists to make better informed decisions during exploratory toxicological studies. The data support that hypothesis on mode of action and discovery of putative biomarkers are tangible outcomes of integrated "omics" analysis. Qualification of biomarkers remains challenging, in particular in terms of identification, mechanistic anchoring, appropriate specificity, and sensitivity.
Laura Suter; Susanne Schroeder; Kirstin Meyer; Jean-Charles Gautier; Alexander Amberg; Maria Wendt; Hans Gmuender; Angela Mally; Eric Boitier; Heidrun Ellinger-Ziegelbauer; Katja Matheis; Friedlieb Pfannkuch
Related Documents :
17476043 - Grid-based analysis of tandem mass spectrometry data in clinical proteomics.
12923783 - The role of bioinformatics in two-dimensional gel electrophoresis.
15506633 - Cost-benefit analysis as a tool for decision making in environmental projects. applicat...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-16
Journal Detail:
Title:  Toxicology and applied pharmacology     Volume:  252     ISSN:  1096-0333     ISO Abbreviation:  Toxicol. Appl. Pharmacol.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-04-12     Completed Date:  2011-06-07     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  0416575     Medline TA:  Toxicol Appl Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  73-84     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug-Related Side Effects and Adverse Reactions / diagnosis,  metabolism*,  pathology*
European Union*
Kidney / drug effects,  metabolism*,  pathology*
Liver / drug effects,  metabolism*,  pathology*
Metabolomics / methods,  trends
Predictive Value of Tests
Proteomics / methods,  trends
Rats, Wistar
Toxicology / methods*,  trends

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of characteristic molecular signature for volatile organic compounds in peripheral bl...
Next Document:  Phytotoxicity of fusaric acid and analogs to cotton.